Amundi’s Zymeworks ZYME Stock Holding History

Amundi’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$353K	Buy	+14,084	New	+$333K	﹤0.01%	1682
2025 Q2	–	Sell	-106	Closed	-$1.25K	–	2213
2025 Q1	$1.25K	Buy	106 +54	+104%	+$736	﹤0.01%	2011
2024 Q4	$735	Buy	+52	New	+$727	﹤0.01%	2063

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Amundi's ZYME Position: Q1 2026 in Review

Amundi opened a new position in Zymeworks (ZYME) in Q1 2026: 14,084 shares worth $353K. The stake represents ﹤0.01% of the portfolio and ranks #1682 among its holdings. This is a return to the name: Amundi previously reported a position in ZYME as recently as Q1 2025.

Amundi first reported a position in ZYME in Q4 2024 and has held it in 3 quarters since. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

Amundi held 14,084 shares of Zymeworks worth $353K as of Q1 2026.
Zymeworks was a new Amundi position in Q1 2026.
Zymeworks made up ﹤0.01% of Amundi's portfolio in Q1 2026, its #1682 holding.
Amundi first reported a position in Zymeworks in Q4 2024 and has held it in 3 quarters since.
211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.